HEADER TOXIN 31-MAY-18 6GNK TITLE EXOENZYME S FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH HUMAN 14-3-3 TITLE 2 PROTEIN BETA, TRIMERIC CRYSTAL FORM BOUND TO CARBA-NAD COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN BETA/ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN 1054,PROTEIN KINASE C INHIBITOR PROTEIN 1,KCIP-1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: EXOENZYME S; COMPND 8 CHAIN: C; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET DUET-1; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 12 ORGANISM_TAXID: 287; SOURCE 13 GENE: EXOS; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 17 EXPRESSION_SYSTEM_PLASMID: PET DUET-1 KEYWDS EXOS, PSEUDOMONAS AERUGINOSA, ADP-RIBOSYLATION, NAD, TOXIN EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.F.PINTO,P.HORNYAK,A.G.THORSELL,K.NAREOJA,H.SCHULER REVDAT 2 17-JAN-24 6GNK 1 REMARK REVDAT 1 26-SEP-18 6GNK 0 JRNL AUTH T.KARLBERG,P.HORNYAK,A.F.PINTO,S.MILANOVA,M.EBRAHIMI, JRNL AUTH 2 M.LINDBERG,N.PULLEN,A.NORDSTROM,E.LOVERLI,R.CARABALLO, JRNL AUTH 3 E.V.WONG,K.NAREOJA,A.G.THORSELL,M.ELOFSSON,E.M.DE LA CRUZ, JRNL AUTH 4 C.BJORKEGREN,H.SCHULER JRNL TITL 14-3-3 PROTEINS ACTIVATE PSEUDOMONAS EXOTOXINS-S AND -T BY JRNL TITL 2 CHAPERONING A HYDROPHOBIC SURFACE. JRNL REF NAT COMMUN V. 9 3785 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 30224724 JRNL DOI 10.1038/S41467-018-06194-1 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 28770 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1439 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.30 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2970 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2806 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2822 REMARK 3 BIN R VALUE (WORKING SET) : 0.2798 REMARK 3 BIN FREE R VALUE : 0.2953 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.98 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 148 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5204 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 90.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 114.4 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 19.55680 REMARK 3 B22 (A**2) : -12.50670 REMARK 3 B33 (A**2) : -7.05020 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 13.42890 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.390 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.425 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.253 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.455 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.261 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5331 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7180 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2567 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 7 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 928 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5331 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 687 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6100 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.75 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.47 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GNK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200010292. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30578 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 48.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 1.28000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3GN0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50% MPD, 8% PEG 8000, 0.1M SODIUM REMARK 280 CACODYLATE, PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 80.46000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.38500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 80.46000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.38500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 GLU A 235 REMARK 465 ASN A 236 REMARK 465 LEU A 237 REMARK 465 TYR A 238 REMARK 465 PHE A 239 REMARK 465 GLN A 240 REMARK 465 SER A 241 REMARK 465 LEU A 242 REMARK 465 GLU A 243 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 GLU B 233 REMARK 465 ASN B 234 REMARK 465 GLU B 235 REMARK 465 ASN B 236 REMARK 465 LEU B 237 REMARK 465 TYR B 238 REMARK 465 PHE B 239 REMARK 465 GLN B 240 REMARK 465 SER B 241 REMARK 465 LEU B 242 REMARK 465 GLU B 243 REMARK 465 MET C 210 REMARK 465 GLY C 211 REMARK 465 SER C 212 REMARK 465 SER C 213 REMARK 465 HIS C 214 REMARK 465 HIS C 215 REMARK 465 HIS C 216 REMARK 465 HIS C 217 REMARK 465 HIS C 218 REMARK 465 HIS C 219 REMARK 465 SER C 220 REMARK 465 GLN C 221 REMARK 465 ASP C 222 REMARK 465 PRO C 223 REMARK 465 ASN C 224 REMARK 465 SER C 225 REMARK 465 GLU C 226 REMARK 465 ASN C 227 REMARK 465 LEU C 228 REMARK 465 TYR C 229 REMARK 465 PHE C 230 REMARK 465 GLN C 231 REMARK 465 PRO C 432 REMARK 465 GLU C 433 REMARK 465 PRO C 434 REMARK 465 SER C 435 REMARK 465 GLY C 436 REMARK 465 GLU C 437 REMARK 465 VAL C 438 REMARK 465 GLN C 439 REMARK 465 GLU C 440 REMARK 465 GLN C 441 REMARK 465 ASP C 442 REMARK 465 VAL C 443 REMARK 465 ARG C 444 REMARK 465 LEU C 445 REMARK 465 ARG C 446 REMARK 465 MET C 447 REMARK 465 ARG C 448 REMARK 465 GLY C 449 REMARK 465 LEU C 450 REMARK 465 ASP C 451 REMARK 465 LEU C 452 REMARK 465 ALA C 453 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 73 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 20 76.71 -114.26 REMARK 500 ARG A 73 -106.49 -120.70 REMARK 500 TYR A 106 -51.10 -123.47 REMARK 500 ARG B 20 76.41 -113.76 REMARK 500 GLU B 33 -9.64 -59.15 REMARK 500 ARG B 73 -85.45 -149.61 REMARK 500 TYR B 106 -51.22 -124.27 REMARK 500 GLN C 256 78.24 -115.61 REMARK 500 ILE C 275 -29.08 -165.57 REMARK 500 ARG C 322 -88.47 -89.74 REMARK 500 ASN C 375 52.95 -148.32 REMARK 500 GLU C 387 18.15 59.39 REMARK 500 GLU C 409 107.20 -54.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CNA C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD C 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GN0 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX IN TETRAMERIC CRYSTAL FORM REMARK 900 RELATED ID: 3GN8 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX IN APO FORM REMARK 900 RELATED ID: 3GNJ RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX COMPLEXED WITH STO1101 DBREF 6GNK A 1 234 UNP P31946 1433B_HUMAN 1 234 DBREF 6GNK B 1 234 UNP P31946 1433B_HUMAN 1 234 DBREF 6GNK C 233 453 UNP Q93SQ1 Q93SQ1_PSEAI 233 453 SEQADV 6GNK GLU A 235 UNP P31946 EXPRESSION TAG SEQADV 6GNK ASN A 236 UNP P31946 EXPRESSION TAG SEQADV 6GNK LEU A 237 UNP P31946 EXPRESSION TAG SEQADV 6GNK TYR A 238 UNP P31946 EXPRESSION TAG SEQADV 6GNK PHE A 239 UNP P31946 EXPRESSION TAG SEQADV 6GNK GLN A 240 UNP P31946 EXPRESSION TAG SEQADV 6GNK SER A 241 UNP P31946 EXPRESSION TAG SEQADV 6GNK LEU A 242 UNP P31946 EXPRESSION TAG SEQADV 6GNK GLU A 243 UNP P31946 EXPRESSION TAG SEQADV 6GNK GLU B 235 UNP P31946 EXPRESSION TAG SEQADV 6GNK ASN B 236 UNP P31946 EXPRESSION TAG SEQADV 6GNK LEU B 237 UNP P31946 EXPRESSION TAG SEQADV 6GNK TYR B 238 UNP P31946 EXPRESSION TAG SEQADV 6GNK PHE B 239 UNP P31946 EXPRESSION TAG SEQADV 6GNK GLN B 240 UNP P31946 EXPRESSION TAG SEQADV 6GNK SER B 241 UNP P31946 EXPRESSION TAG SEQADV 6GNK LEU B 242 UNP P31946 EXPRESSION TAG SEQADV 6GNK GLU B 243 UNP P31946 EXPRESSION TAG SEQADV 6GNK MET C 210 UNP Q93SQ1 INITIATING METHIONINE SEQADV 6GNK GLY C 211 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK SER C 212 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK SER C 213 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK HIS C 214 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK HIS C 215 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK HIS C 216 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK HIS C 217 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK HIS C 218 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK HIS C 219 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK SER C 220 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK GLN C 221 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK ASP C 222 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK PRO C 223 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK ASN C 224 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK SER C 225 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK GLU C 226 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK ASN C 227 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK LEU C 228 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK TYR C 229 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK PHE C 230 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK GLN C 231 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK GLY C 232 UNP Q93SQ1 EXPRESSION TAG SEQADV 6GNK ALA C 379 UNP Q93SQ1 GLU 379 ENGINEERED MUTATION SEQADV 6GNK ALA C 381 UNP Q93SQ1 GLU 381 ENGINEERED MUTATION SEQRES 1 A 243 MET THR MET ASP LYS SER GLU LEU VAL GLN LYS ALA LYS SEQRES 2 A 243 LEU ALA GLU GLN ALA GLU ARG TYR ASP ASP MET ALA ALA SEQRES 3 A 243 ALA MET LYS ALA VAL THR GLU GLN GLY HIS GLU LEU SER SEQRES 4 A 243 ASN GLU GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN SEQRES 5 A 243 VAL VAL GLY ALA ARG ARG SER SER TRP ARG VAL ILE SER SEQRES 6 A 243 SER ILE GLU GLN LYS THR GLU ARG ASN GLU LYS LYS GLN SEQRES 7 A 243 GLN MET GLY LYS GLU TYR ARG GLU LYS ILE GLU ALA GLU SEQRES 8 A 243 LEU GLN ASP ILE CYS ASN ASP VAL LEU GLU LEU LEU ASP SEQRES 9 A 243 LYS TYR LEU ILE PRO ASN ALA THR GLN PRO GLU SER LYS SEQRES 10 A 243 VAL PHE TYR LEU LYS MET LYS GLY ASP TYR PHE ARG TYR SEQRES 11 A 243 LEU SER GLU VAL ALA SER GLY ASP ASN LYS GLN THR THR SEQRES 12 A 243 VAL SER ASN SER GLN GLN ALA TYR GLN GLU ALA PHE GLU SEQRES 13 A 243 ILE SER LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG SEQRES 14 A 243 LEU GLY LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU SEQRES 15 A 243 ILE LEU ASN SER PRO GLU LYS ALA CYS SER LEU ALA LYS SEQRES 16 A 243 THR ALA PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU SEQRES 17 A 243 ASN GLU GLU SER TYR LYS ASP SER THR LEU ILE MET GLN SEQRES 18 A 243 LEU LEU ARG ASP ASN LEU THR LEU TRP THR SER GLU ASN SEQRES 19 A 243 GLU ASN LEU TYR PHE GLN SER LEU GLU SEQRES 1 B 243 MET THR MET ASP LYS SER GLU LEU VAL GLN LYS ALA LYS SEQRES 2 B 243 LEU ALA GLU GLN ALA GLU ARG TYR ASP ASP MET ALA ALA SEQRES 3 B 243 ALA MET LYS ALA VAL THR GLU GLN GLY HIS GLU LEU SER SEQRES 4 B 243 ASN GLU GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN SEQRES 5 B 243 VAL VAL GLY ALA ARG ARG SER SER TRP ARG VAL ILE SER SEQRES 6 B 243 SER ILE GLU GLN LYS THR GLU ARG ASN GLU LYS LYS GLN SEQRES 7 B 243 GLN MET GLY LYS GLU TYR ARG GLU LYS ILE GLU ALA GLU SEQRES 8 B 243 LEU GLN ASP ILE CYS ASN ASP VAL LEU GLU LEU LEU ASP SEQRES 9 B 243 LYS TYR LEU ILE PRO ASN ALA THR GLN PRO GLU SER LYS SEQRES 10 B 243 VAL PHE TYR LEU LYS MET LYS GLY ASP TYR PHE ARG TYR SEQRES 11 B 243 LEU SER GLU VAL ALA SER GLY ASP ASN LYS GLN THR THR SEQRES 12 B 243 VAL SER ASN SER GLN GLN ALA TYR GLN GLU ALA PHE GLU SEQRES 13 B 243 ILE SER LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG SEQRES 14 B 243 LEU GLY LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU SEQRES 15 B 243 ILE LEU ASN SER PRO GLU LYS ALA CYS SER LEU ALA LYS SEQRES 16 B 243 THR ALA PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU SEQRES 17 B 243 ASN GLU GLU SER TYR LYS ASP SER THR LEU ILE MET GLN SEQRES 18 B 243 LEU LEU ARG ASP ASN LEU THR LEU TRP THR SER GLU ASN SEQRES 19 B 243 GLU ASN LEU TYR PHE GLN SER LEU GLU SEQRES 1 C 244 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 C 244 PRO ASN SER GLU ASN LEU TYR PHE GLN GLY ALA ASP LYS SEQRES 3 C 244 ALA LEU ALA ASP GLY LEU VAL LYS ARG PHE GLY ALA ASP SEQRES 4 C 244 ALA GLU LYS TYR LEU GLY ARG GLN PRO GLY GLY ILE HIS SEQRES 5 C 244 SER ASP ALA GLU VAL MET ALA LEU GLY LEU TYR THR GLY SEQRES 6 C 244 ILE HIS TYR ALA ASP LEU ASN ARG ALA LEU ARG GLN GLY SEQRES 7 C 244 GLN GLU LEU ASP ALA GLY GLN LYS LEU ILE ASP GLN GLY SEQRES 8 C 244 MET SER ALA ALA PHE GLU LYS SER GLY GLN ALA GLU GLN SEQRES 9 C 244 VAL VAL LYS THR PHE ARG GLY THR ARG GLY GLY ASP ALA SEQRES 10 C 244 PHE ASN ALA VAL GLU GLU GLY LYS VAL GLY HIS ASP ASP SEQRES 11 C 244 GLY TYR LEU SER THR SER LEU ASN PRO GLY VAL ALA ARG SEQRES 12 C 244 SER PHE GLY GLN GLY THR ILE SER THR VAL PHE GLY ARG SEQRES 13 C 244 SER GLY ILE ASP VAL SER GLY ILE SER ASN TYR LYS ASN SEQRES 14 C 244 ALA LYS ALA ILE LEU TYR ASN LYS GLU THR ASP MET ARG SEQRES 15 C 244 VAL LEU LEU SER ALA SER ASP GLU GLN GLY VAL THR ARG SEQRES 16 C 244 ARG VAL LEU GLU GLU ALA ALA LEU GLY GLU LEU SER GLY SEQRES 17 C 244 HIS SER GLN GLY LEU LEU ASP ALA LEU ASP LEU ALA SER SEQRES 18 C 244 LYS PRO GLU PRO SER GLY GLU VAL GLN GLU GLN ASP VAL SEQRES 19 C 244 ARG LEU ARG MET ARG GLY LEU ASP LEU ALA HET CNA C 501 44 HET MPD C 502 8 HETNAM CNA CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL FORMUL 4 CNA C22 H30 N7 O13 P2 1+ FORMUL 5 MPD C6 H14 O2 FORMUL 6 HOH *26(H2 O) HELIX 1 AA1 ASP A 4 ALA A 18 1 15 HELIX 2 AA2 ARG A 20 GLN A 34 1 15 HELIX 3 AA3 SER A 39 THR A 71 1 33 HELIX 4 AA4 ASN A 74 TYR A 106 1 33 HELIX 5 AA5 GLN A 113 ALA A 135 1 23 HELIX 6 AA6 GLY A 137 MET A 162 1 26 HELIX 7 AA7 HIS A 166 ILE A 183 1 18 HELIX 8 AA8 SER A 186 GLU A 204 1 19 HELIX 9 AA9 LEU A 205 LEU A 208 5 4 HELIX 10 AB1 SER A 212 SER A 232 1 21 HELIX 11 AB2 ASP B 4 ALA B 18 1 15 HELIX 12 AB3 ARG B 20 GLN B 34 1 15 HELIX 13 AB4 SER B 39 THR B 71 1 33 HELIX 14 AB5 ASN B 74 TYR B 106 1 33 HELIX 15 AB6 GLN B 113 ALA B 135 1 23 HELIX 16 AB7 GLY B 137 MET B 162 1 26 HELIX 17 AB8 HIS B 166 ILE B 183 1 18 HELIX 18 AB9 SER B 186 GLU B 204 1 19 HELIX 19 AC1 LEU B 205 LEU B 208 5 4 HELIX 20 AC2 SER B 212 THR B 231 1 20 HELIX 21 AC3 ALA C 233 GLY C 246 1 14 HELIX 22 AC4 GLY C 246 LYS C 251 1 6 HELIX 23 AC5 SER C 262 ILE C 275 1 14 HELIX 24 AC6 HIS C 276 GLY C 287 1 12 HELIX 25 AC7 ASP C 291 GLY C 309 1 19 HELIX 26 AC8 ASN C 347 SER C 353 1 7 HELIX 27 AC9 ASN C 375 ALA C 379 5 5 HELIX 28 AD1 ALA C 411 GLY C 413 5 3 HELIX 29 AD2 GLY C 421 LEU C 426 1 6 SHEET 1 AA1 5 VAL C 315 THR C 321 0 SHEET 2 AA1 5 THR C 358 GLY C 364 -1 O GLY C 364 N VAL C 315 SHEET 3 AA1 5 THR C 403 GLU C 409 1 O GLU C 409 N PHE C 363 SHEET 4 AA1 5 ASP C 389 SER C 397 -1 N ARG C 391 O GLU C 408 SHEET 5 AA1 5 VAL C 335 HIS C 337 -1 N GLY C 336 O MET C 390 SHEET 1 AA2 3 LEU C 342 SER C 345 0 SHEET 2 AA2 3 ALA C 381 TYR C 384 -1 O TYR C 384 N LEU C 342 SHEET 3 AA2 3 ILE C 368 ASP C 369 -1 N ILE C 368 O LEU C 383 SITE 1 AC1 20 GLU A 233 ASN A 234 THR C 273 TYR C 277 SITE 2 AC1 20 ASN C 281 ARG C 285 ARG C 319 GLY C 320 SITE 3 AC1 20 THR C 321 ARG C 322 GLY C 323 GLY C 324 SITE 4 AC1 20 ALA C 326 ASP C 338 SER C 343 THR C 344 SITE 5 AC1 20 SER C 345 PHE C 354 HOH C 601 HOH C 607 SITE 1 AC2 4 ARG A 224 GLY C 274 ILE C 275 TYR C 376 CRYST1 160.920 56.770 120.350 90.00 126.45 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006214 0.000000 0.004590 0.00000 SCALE2 0.000000 0.017615 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010330 0.00000